New Olympus OEV321UH Monitor Brings Value, Expansion of 4K Offering and a Range of Compatibility Options for Endoscopy and Surgical Suites

Olympus announced today the availability of a new monitor option, the OEV321UH video display monitor, a 32-inch Ultra High Definition 4K monitor that expands upon Olympus 4K monitor offerings. Backward- and forward-compatible with most Olympus processors, the new monitor provides a breadth of customizable uses at an attractive price point.

“With this new OEV321UH Monitor, customers can upgrade their endoscopy suites and ORs to have larger screens that will be important to their practices for a range of cases,” said Kevin Mancini, Business Unit Vice President, Endoscopy Division, Olympus America, Inc. “Visualization improvements can translate into meaningful practice improvements that elevate the standard of care.”

The OEV321UH video monitor features includei:

  • Design compatible with future systems, including 12G-SDI connections for single cable 4K routing;
  • A 32-inch screen for a larger viewing area, following an observed customer trendii
  • Compatibility with a range of endoscopy and surgical systems;
  • Fully adjustable design to address specific viewing needs;
  • CLONE OUT function, which is used to duplicate the main monitor’s HD/4K display for use on a second monitor or on a recording device, including PIP/POP (picture-in-picture/picture-out-picture) display;
  • Split screen functionality and compatibility with telecollaboration tools;
  • Advanced Image Multiple Enhancer (A.I.M.E.) for sharp, vivid image of structures without increasing noise: creates enhanced texture that supports more detailed observation;
  • Flat display and detachable cable cover for quick and easy monitor cleaning; access window in cable cover also allows for convenient cable routing.

Since its development of the first flexible gastroscope in 1950, Olympus has continued to bring new endoscopy and surgical innovations to market, while also delivering excellent service, support and ongoing training toward workflow optimization and operational efficiency. Olympus products and services meet a range of procedural needs, which means customers have the tools they need to stay at the forefront of their fields, as they work to help patients live longer, healthier lives.

For more information about the OEV321UH, visit here.

i Data on file with Olympus (DC00675762).

ii https://www.aorn.org/outpatient-surgery/articles/outpatient-surgery-magazine/2017/february/does-size-matter-when-it-comes-to-surgical-displays

SourceOlympus

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”